15-Bromo-2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecine

Catalog No. :
ACRWGX490
CAS No. :
60835-72-5
Molecular Formula :
C14H19BrO5
Molecular Weight :
347.20

IUPAC Name:15-bromo-2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecine

15-Bromo-2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$93.00Login to see priceIn stockInquiry
5g98%$464.00Login to see priceIn stockInquiry
25g98%$1670.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name15-Bromo-2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecine
IUPAC Name15-bromo-2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecine
MDL No.MFCD00143270
Molecular FormulaC14H19BrO5
Molecular Weight347.20
SMILESBrC1=CC=C2OCCOCCOCCOCCOC2=C1
InChI KeyGPKJNSIFVWMEEI-UHFFFAOYSA-N
Synonym4'-Bromobenzo-15-crown 5-Ether | 4-BROMOBENZO-15-CROWN 5-ETHER | BS-52283 | 15-bromo-2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecine | CS-0197318 | SR-01000395834-2 | Z57035386 | 15-Bromo-2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,
CAS No.60835-72-5
PubChem CID2724799

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRWGX490 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWGX490 route product structure diagram
    ACRWGX49060835-72-5 In Stock
Inquiry

2. ACRWGX490 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWGX490 route product structure diagram
    ACRWGX49060835-72-5 In Stock
Inquiry

Comments (0)